DrAIStudio

OncoImmunology call for papers

Current call-for-papers opportunities for OncoImmunology. Ranking signals: Indexed (Active), JIF 6.3. Use the official publisher page to verify scope and submission rules.

Accepting CFPs for OncoImmunology

Advances in Adoptive Cell Therapies

Deadline 2026-12-31Taylor & FrancisIndexed (Active)

Journal: OncoImmunology

Adoptive cell therapies (ACT) have recently taken center stage in cancer immunotherapy, largely due to the success of chimeric antigen receptor (CAR-T) cell therapies in treating hematologic malignancies. In ACT, patient immune cells are collected, engineered ex vivo to strengthen anti-tumor immunity, expanded, and then infused back into the patient. From infusions of tumor-infiltrating lymphocytes (TIL) to the deve…

Generate research ideas Open CFP source Submit

Reference integrity note: verify every citation against the original source before submission, including publication year, journal title, volume/issue, page range, DOI, and the target journal style.